Pantaleo G, Janes H, Karuna S, et al. Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial. Lancet HIV 2019; 6: e737–49—In this Article, the label and data for the study group T4 in the right hand panel of figure 3C were presented incorrectly. This correction was made on Jan 9, 2020.

中文翻译：

---

柳叶刀艾滋病毒更正2019; 6：e737-49。

Pantaleo G，Janes H，Karuna S等。包含包膜蛋白和DNA或NYVAC载体（HVTN 096）的多价HIV疫苗的安全性和免疫原性：1b期，双盲，安慰剂对照试验。柳叶刀艾滋病毒2019; 6：e737-49 —在本文中，图3C右面板中T4研究组的标签和数据显示不正确。更正于2020年1月9日进行。